Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
Clinical trial NCT03199313 · COMPLETED
Trial details
- NCT number
- NCT03199313
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2017-12-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.